According to foreign media reports,The US Food and Drug Administration (FDA) released a report last week, disclosing a variety of child drugs including Robitussin and DimeTApp have been recalled.This recall involves two batches of non-prescribed drugs, 4 ounces and 8 ounces of cough and cold drugs. According to FDA disclosure, after discovering the problem, Glaxo-consumer healthcare company took the initiative to recall.
It is usually caused by two reasons when it comes to drug recall issues: Some of the components in the drug are found to use the wrong dose level to place the patient in the risk of excess or insufficient drug; or some type of drug contamination Furthermore, a certain degree of adverse reactions is in the patient.
This time is not the case – good news is that parents don’t have to worry about whether the non-prescription drugs taken by children will make potential threats to their health. Instead, GSK Consumer Health Company has actively recalled these two RobitusSin and DimeTAPP because it was found that the metering cups included in these products lack some measurement markers.
Liquid drugs such as cough syrup are usually equipped with a small plastic cup, used to fill the drug and measure the correct dose, and there is a small number of small lines indicate such as 5 ml and 10 ml. This is very convenient, because many people have no ready-made dose cups or syringes.
According to the recall notice, the GSK found that some plastic amount cups included with these drugs lack some measurement markers. In the recall of children Robitussin Hoeny, the cup may lack of 5 ml or 10 ml of tags. In the recalled children dimeetApp, the cup may lack 10ml tags.